October Pharma S.A.E (EGX:OCPH)

Egypt · Delayed Price · Currency is EGP

480.00

-16.80 (-3.38%)

At close: Aug 4, 2026

October Pharma S.A.E Financials Overview

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,462	1,228	1,012	727.37	655.04	543.4
Revenue Growth	22.51%	21.39%	39.08%	11.04%	20.54%	3.88%
Gross Profit	620.57	523.39	496.2	352.03	323.29	251.54
Operating Income	379.07	320.57	307.06	199.23	195.54	145.04
Net Income	165.09	131.26	150.4	113.73	119.79	88.26
Earnings Per Share	13.76	10.94	12.53	9.48	9.98	7.35
EPS Growth	4.39%	-12.72%	32.24%	-5.06%	35.73%	160.91%

Revenue by Geography

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Egypt	1,310	1,139	933.25
Export	151.75	89.23	78.4
Total	1,462	1,228	1,012

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	68.51	52.52	45.3	6.92	16.72	1.86
Total Debt	425.07	552.32	323.98	322.79	74.15	248.32
Net Cash (Debt)	-356.56	-499.8	-278.68	-315.87	-57.43	-246.46
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-29.71	-41.65	-23.22	-26.32	-4.79	-20.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	371.22	43.24	153.29	-92.33	262.13	53.3
Capital Expenditures	-15.55	-53.06	-35.31	-92.67	-19.7	-5.65
Free Cash Flow	355.67	-9.82	117.98	-185	242.43	47.65
Free Cash Flow Growth	-	-	-	-	408.80%	-24.17%

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	42.45%	42.62%	49.05%	48.40%	49.35%	46.29%
Operating Margin	25.93%	26.10%	30.35%	27.39%	29.85%	26.69%
Pretax Margin	15.91%	16.53%	24.19%	23.85%	25.14%	20.83%
Profit Margin	11.29%	10.69%	14.87%	15.63%	18.29%	16.24%
FCF Margin	24.33%	-0.80%	11.66%	-25.43%	37.01%	8.77%

Dividends

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Dividend Per Share	2.500	-	-	1.500
Dividend Per Share Growth	-	-	-	-
Dividend Yield	2.56%	-	-	3.25%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PE Ratio	34.89	9.98	7.98	10.55	8.16	6.80
P/FCF Ratio	16.19	-	10.17	-	4.04	12.59
PS Ratio	3.94	1.07	1.19	1.65	1.49	1.10